Human Pharmaceutical Portfolio

Terigen 14 mg Capsule

Product information from the Times Medicament supplied portfolio. Contact our export team to confirm current sourcing options, market requirements and commercial availability.

Molecule / StrengthTeriflunomide 14 mg
ManufacturerNuvigen Life Sciences Pvt Ltd
CategoryMultiple Sclerosis
This product is listed in the supplied Times Medicament unregistered product portfolio. Listing does not by itself confirm registration, licensing or availability in any specific country. Market-specific confirmation is required.